Drug Profile
Poliovirus vaccine oral - Bilthoven Biologicals
Alternative Names: BBio Bivalent Oral Polio Vaccine - Bilthoven Biologicals; BBio bOPV - Bilthoven BiologicalsLatest Information Update: 23 Feb 2022
Price :
$50
*
At a glance
- Originator Bilthoven Biologicals
- Developer Serum Institute of India
- Class Viral vaccines; Viruses
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Poliomyelitis
Most Recent Events
- 23 Feb 2022 No development reported - Phase-III for Poliomyelitis (In children, In infants, Prevention) in Bangladesh (PO)
- 14 Feb 2018 Bilthoven Biologicals and Serum Institute of India completes a phase III trial in Poliomyelitis (In children, In infants, Prevention) in Bangladesh (PO) (NCT02766816)
- 01 May 2016 Phase-III clinical trials in Poliomyelitis (In children, In infants, Prevention) in Bangladesh (PO) (NCT02766816)